Resources for healthcare professionals, to support your daily practice with TIVICAY and TRIUMEQ
For journalists and analysts, recent press releases and media contacts are available on ViiVHealthcare.com
Thank you for choosing to report an adverse event.
ViiV routinely monitors the safety of all its medicines. This includes review of safety data from clinical studies, and collection of reports and cases of adverse events for marketed products.
This information contributes to the continuing safety surveillance of our products. If you become aware of a patient who has experienced an adverse event, pregnancy, overdose or unexpected benefits with one of our products, we would be grateful if you would contact ViiV at email@example.com.
ViiV does not recommend, endorse or accept liability for sites controlled by third-parties.
This is the main message
Please choose one of the following:
To access the press material, please enter below the password you received in your email